Blood diagnosis for Alzheimer’s disease
Amoneta Diagnostics develops an innovative method for Alzheimer’s diagnosis under an exclusive license agreement with CNRS (owner of the patents). The test can be performed on very small blood samples, since only one drop is enough. It used genuine fluorescent probes, which recognize biological markers specific for Alzheimer’s patients.
The test has numerous advantages as compared to other methods: it is easy to use, not painful, quick and cost effective.